Profile picture

Doctor Thomas M Hofbauer

Medical University of Vienna, Vienna (Austria)
Membership: FESC Member
Follow
Logo ESC

Contributor content

PAH-specific treatment for patients with combined pre- and post-capillary pulmonary hypertension
Presentation
PAH-specific treatment for patients with combined pre- and post-capillary pulmonary hypertension
Proteomic profiling of acute stent thrombi reveals critical involvement of the complement system
Presentation
Proteomic profiling of acute stent thrombi reveals critical involvement of the complement system
Deficiency in milk fat globule-epidermal growth factor 8 delays thrombus resolution
Presentation
Deficiency in milk fat globule-epidermal growth factor 8 delays thrombus resolution
The Q222R deoxyribonuclease 1 single nucleotide polymorphism independently predicts mortality in patients with coronary artery disease after ST-elevation myocardial infarction
Presentation
The Q222R deoxyribonuclease 1 single nucleotide polymorphism independently predicts mortality in patients with coronary artery disease after ST-elevation myocardial infarction
Neutrophil extracellular trap formation is enhanced in arterial hypertension via and AT1R and NADPH oxidase-dependent pathway
Presentation
Neutrophil extracellular trap formation is enhanced in arterial hypertension via and AT1R and NADPH oxidase-dependent pathway
The single nucleotide polymorphism Q222R in the DNase 1 gene is linked with mortality in patients after ST-elevation myocardial infarction.
Presentation
The single nucleotide polymorphism Q222R in the DNase 1 gene is linked with mortality in patients after ST-elevation myocardial infarction.
Angiotensin-II enhances neutrophil extracellular trap formation in an AT1R and NADPH oxidase-dependent manner
Presentation
Angiotensin-II enhances neutrophil extracellular trap formation in an AT1R and NADPH oxidase-dependent manner
BMPRII signaling of fibrocytes, a mesenchymal progenitor cell population, is increased in STEMI and dyslipidemia
Presentation
BMPRII signaling of fibrocytes, a mesenchymal progenitor cell population, is increased in STEMI and dyslipidemia

ESC 365 is supported by